Evaxion announces business update and third quarter 2024 financial results

Copenhagen, denmark, october 31, 2024 - evaxion biotech a/s (nasdaq: evax) (“evaxion”), a clinical-stage techbio company specializing in developing ai-immunology™ powered vaccines, provides business update and announces third quarter 2024 financial results.

EVAX Ratings Summary

EVAX Quant Ranking